NDC Code(s) : 24979-200-01, 24979-200-02, 24979-200-03
Packager : TWi Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Dicyclomine HydrochlorideDicyclomine Hydrochloride TABLET | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
LABELER - TWi Pharmaceuticals, Inc.(658402052) |
REGISTRANT - TWi Pharmaceuticals, Inc.(658402052) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
TWi Pharmaceuticals, Inc. Zhongli Plant | 658863394 | manufacture(24979-200), analysis(24979-200), pack(24979-200) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
BORA PHARMACEUTICAL LABORATORIES INC. | 656139511 | manufacture(24979-200), analysis(24979-200), pack(24979-200) |
PRINCIPAL DISPLAY PANEL
NDC 24979-200-01
Dicyclomine Hydrochloride Tablets, USP
20 mg
Rx only
100 Tablets
TWi
PRINCIPAL DISPLAY PANEL
NDC 24979-200-03
Dicyclomine Hydrochloride Tablets, USP
20 mg
Rx only
1000 Tablets
TWi